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A sixty-years-old male with diagnosis of a left adrenal mass (146 × 99 × 126mm) with associated tumour thrombosis of the left
renal vein with no clear signs of thrombosis of the inferior vena cava was admitted for elective surgery Finally an adrenalectomy
and excision of tumour thrombus preserving the ipsilateral kidney was made. Despite of the complex vascular management, this
kind of approaches allow to preserve normal renal function in patients with future nephrotoxic treatment like cisplatin.
Copyright © 2009 Manuel P´ erez Utrilla et al. This is an open access article distributed under the Creative Commons Attribution
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1.Introduction
Primary adrenocortical carcinoma is a tumour of low
incidence and poor prognosis. Between 0.05% and 0.2% of
cancer deaths are due to this tumour [1].
Its poor prognosis is due mainly to the absence of
eﬀective adjuvant treatment and the delay in diagnosis,
caused by two factors. In ﬁrst place, its anatomical location
allows it to reach a considerable size without causing
symptoms. Secondly, approximately 50% of large suprarenal
masses are functioning, causing Cushing’s syndrome in most
cases while the remainder is diagnosed incidentally [2].
Although the prognostic factors are unclear, various
studies indicate that surgical resection of the mass may
improve survival rates and even in those advanced cases in
which complete oncological resection is not possible, and it
may help to improve the results of chemotherapy [3].
2.CaseReport
Sixty-year old male with no medical history of interest was
referred to the Urology Department with the incidental
ﬁnding of a left renal mass and space-occupying lesions
(SOL) in the liver. Physical examination revealed a mobile,
slightly painful mass in the left hypochondrium. Laboratory
tests found high levels of alkaline phosphatase (350IU/l),
GGT (115IU/l), and LDH (883IU/l). Analytical studies
showed normal adrenal hormones in blood and urine.
Abdominal ultrasound revealed a left renal mass of
heterogeneous echogenicity. Multiple liver SOLs were also
identiﬁed (most about 6cm in diameter) in the right liver
lobe and an image suggestive of a cyst in the head of
the pancreas. An axial tomography was performed (thorax-
abdominal-pelvic slices) with intravenous contrast which
showed the presence of multiple pulmonary nodules, some
larger than 1cm in diameter, suggestive of metastases, and
Left suprarenal mass, 146 × 99 × 126mm, suggestive of
malignancy, with no separation from the kidney and which
displaced the pancreas and spleen with no clear signs of
inﬁltration. Tumour thrombosis involves suprarenal vein
and left renal vein with no clear signs of thrombosis of the
inferior vena cava (IVC) (Figure 1).
He was admitted for elective surgery with a diagnosis of
left adrenocortical carcinoma with thrombosis of left renal2 Advances in Urology
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Figure 1: Pre- (a) and postoperative (b) CT scan showing tumour
thrombosis of the left renal vein and later vascular result.
vein and liver and lung metastases. A bilateral subcostal
incisionwasmade.Mobilisationofleftcolonandsplenorenal
ligaments expose a large left suprarenal mass with renal
vein thrombosis and signiﬁcant tumour adhesions. After
dissection of the renal hilum (double artery and single vein),
the suprarenal vein was then dissected. The renal vein was
clamped at vena cava ostium, the renal hilum was clamped
en bloc, and venotomy was performed in the proximal
third. Complete dissection and enucleation of the tumour
thrombus, closure with Prolene 5/0 and unclamping, check
the haemostasia. The left suprarenal vein was then tied and
the surgical specimen was excised, preserving the ipsilateral
kidney. Finally, regional lymphadenectomy was performed.
The anatomical pathology diagnosis was adrenocortical
carcinomameasuring15cm ×6cm×11cm(initslongitudi-
nal, transverse, and anteroposterior diameters) with tumour
embolismintheleftrenalvein,measuring4cm ×2cm×1cm
(L × T × AP). None of the adenopathies were inﬁltrated, a
total of 9 having been excised (Figures 2 and 3).
Thepatientwasdischarged6daysaftersurgery,withnor-
mal creatinine levels and no complications. He is presently
on treatment with mitotane in increasing doses awaiting to
associate treatment with adriamycin and cisplatin.
Figure 2: Inhibin expression (immunohistochemistry); origin
marker in adrenal cortex.
Figure 3:Papillarfragmentofembolizedtumourwithnecroticaxis
and viable tumoral surface.
3. Discussion
Adrenocortical carcinoma may have renal vein tumour
thrombosis, ranging from 9% to 19% of cases [4]. It is pre-
cisely in these cases when we have to consider the indication
of ipsilateral nephrectomy combined with adrenalectomy
and excision of the tumour thrombus. According to liter-
ature [5–7], of the 121 published cases of adrenalectomies
with associated tumour thrombosis (AATT), 71.2% of
cases were primary adrenocortical carcinomas, 15.8% were
phaeochromocytomas, 5.5% were neuroblastomas, 2.5%
were leiomyosarcomas, and 5% were metastases of diverse
origin (transitional cell carcinoma of the renal pelvis, small
cell lung cancer, thyroid cancer, and Wilms’ tumour).
Massive involvement of the inferior vena cava or inﬁl-
tration of the venous wall itself may be considered limiting
factors for the surgical indication, also bearing in mind the
poor prognosis of adrenocortical cancer and the technical
diﬃculties that adequate vascular control and its subsequent
reconstruction entail. For this reason, the preoperative study
of the tumour thrombosis and the involvement of the
renal vein and/or inferior vena cava has become particularly
important. Computerised axial tomography (CT) and mag-
neticresonance(MR)areconsideredtwoimagingtechniquesAdvances in Urology 3
whichareofmostvalueinvascularstudy,takingintoaccount
that MR also oﬀers the advantage of properly distinguishing
between a ﬁbrinogenic and a tumour thrombus [8].
The approach should therefore be planned considering
factors such as the size of the suprarenal mass, the upper
limit of the tumour venous thrombosis, and the need
for procedures associated with the adrenalectomy, such as
nephrectomy, splenectomy, regional lymphadenectomy, and
others [7]. Our team prefers to preserve the ipsilateral kidney
in these cases, provided that it has no local inﬁltration. This
is not always technically possible, and hence, in the study by
Lucon et al. [6], the 8AATT (3 phaeochromocytomas and
5 adrenocortical carcinomas) was combined with ipsilateral
nephrectomy. Similarly, Chiche et al. [7] carried out a liter-
ature review and presented their experience with 15AATT.
They combined ipsilateral nephrectomy in 10 cases. Another
nephrectomy was subsequently performed due to ischaemia
after excision of the thrombus, highlighting the complex
vascular approach in these types of interventions when
attempting to preserve the renal function. In the anatomical
pathology ﬁndings, 8 of the 11 renal specimens did not show
inﬁltration by the adrenal carcinoma. Therefore, according
to two of the most extensive AATT series [6, 7], the
percentage of preservation of the ipsilateral kidney was
17.4% (4 preserved of 23 possible).
The role of chemotherapy is controversial. Although
variousauthorsrecommendearlypostsurgicalregimenswith
mitotane [4], only partial responses have been described
without an impact on survival [9]. The best results have
been achieved with the combination of etoposide, cisplatin,
and doxorubicin associated with mitotane, with response
rates varying between 10% and 55% [10]. There are patients
who respond well to the combination of surgery and
chemotherapy, with a disease-free survival of 27.6% between
12 and 80 months after the end of chemotherapy [4].
4. Conclusion
We present a case of adrenalectomy and excision of a
tumour thrombus preserving the ipsilateral kidney. There
are objective data on patients with a good response to
the combination of surgery and chemotherapy, and this
justiﬁes an attempt to preserve the renal function, despite
the complex vascular approach. Consequently, prospective
studies with a suﬃcient number of patients are necessary.
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